BioArctic AB's (publ) partner Eisai will present new clinical and real-world evidence on lecanemab (Leqembi®) at the Alzheimer's Association International Conference (AAIC) in London, July 12-15, ...
Delphi Lane home was vacant and still under construction at the time of the blaze, Office of the Fire Marshal is ...
Eisai Co., Ltd. announced today the company will present the latest findings from its Alzheimer's disease (AD) research, including lecanemab (brand name: LEQEMBI®), our anti-amyloid beta (A?) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果